In a study addressing mechanisms imparting resistance to ALK inhibitors in eight different lines of neuroblastoma cells, EC50 values for decreases in cell viability varied from 10 to 100 nM in five cell lines and ranged around 1 μM in three others (Trigg et al. 2019). The gene discussed is ALK; the disease is neuroblastoma.